Thai Nguyen City

Resilience Network


You are here

Demographics

For older patients, Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief --two new studies

New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.

Benefit seen only in older patients

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Demographics
howdy folks
Page loaded in 0.605 seconds.